SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $101,127,280 | +31.9% | 53,865,000 | +17.1% | 3.93% | +33.4% |
| Q3 2022 | $76,672,000 | -30.9% | 45,997,000 | -47.5% | 2.94% | -33.6% |
| Q2 2022 | $111,032,000 | -3.6% | 87,599,000 | +0.1% | 4.43% | +23.6% |
| Q1 2022 | $115,167,000 | -4.5% | 87,499,000 | +6.1% | 3.58% | -4.3% |
| Q4 2021 | $120,618,000 | -12.8% | 82,499,000 | -11.3% | 3.75% | -9.2% |
| Q3 2021 | $138,298,000 | +12.5% | 92,999,000 | 0.0% | 4.13% | +12.0% |
| Q2 2021 | $122,964,000 | +5.6% | 92,999,000 | +4.5% | 3.68% | -8.0% |
| Q1 2021 | $116,446,000 | -20.1% | 88,999,000 | +49.2% | 4.00% | +4.5% |
| Q4 2020 | $145,743,000 | +14.2% | 59,662,000 | -3.2% | 3.83% | -11.0% |
| Q3 2020 | $127,669,000 | -9.8% | 61,662,000 | 0.0% | 4.30% | -16.9% |
| Q2 2020 | $141,593,000 | +67.3% | 61,662,000 | +11.6% | 5.18% | +25.4% |
| Q1 2020 | $84,644,000 | -22.8% | 55,277,000 | -2.0% | 4.13% | -16.3% |
| Q4 2019 | $109,667,000 | +340.6% | 56,378,000 | +199.1% | 4.94% | +191.6% |
| Q3 2019 | $24,892,000 | +73.7% | 18,851,000 | +106.1% | 1.69% | +38.8% |
| Q2 2019 | $14,334,000 | -47.1% | 9,145,000 | -39.0% | 1.22% | -48.0% |
| Q1 2019 | $27,120,000 | – | 15,000,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |